Certain classes of genes in patients that could lead to prostate cancer

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

Investigational PD-L1–targeted immunotherapy safe for patients with triple-negative breast cancer

PARP inhibitor combo shows early promise for patients with and without BRCA mutations

Phase II trial of ipilimumab-nivolumab combo shows promise in advanced melanoma

New immunotherapy yields long-lasting responses in some patients with advanced melanoma

Incidences of liver cancer rising in the USA

New data shows that generic drivers are found in benign conditions

What are the objectives for CART-meso immunotherapy?

New T cell–based immunotherapy shows promise for lethal stem cell transplant complication

How will genomics be applied to patient therapy in future?

ecancermedicalscience editor's choice for April 2015